Titlebook: Bisphosphonates in Clinical Oncology; The Development of P Beat Thürlimann Book 1999 Springer-Verlag Berlin · Heidelberg 1999 Metastatic Bo

只看該作者 · 發(fā)表于 2025-3-23 12:45:59

Recent Results in Cancer Researchhttp://image.papertrans.cn/b/image/188891.jpg

只看該作者 · 發(fā)表于 2025-3-23 15:26:38

https://doi.org/10.1007/978-3-642-59845-6Metastatic Bone Disease; Palliation; Pamidronate; Vitamin D; bisphosphonates; breast cancer; hormones; inte

只看該作者 · 發(fā)表于 2025-3-23 21:15:40

只看該作者 · 發(fā)表于 2025-3-24 01:03:35

只看該作者 · 發(fā)表于 2025-3-24 05:12:13

只看該作者 · 發(fā)表于 2025-3-24 10:07:40

只看該作者 · 發(fā)表于 2025-3-24 13:21:19

Bisphosphonates in Clinical Oncology978-3-642-59845-6Series ISSN 0080-0015 Series E-ISSN 2197-6767

只看該作者 · 發(fā)表于 2025-3-24 17:28:29

,Einführung in die Linsentheorie (27–46),The pharmacological approach to disorders of bone remodeling is based mainly on drugs that inhibit osteoclastic bone resorption. Fewer advances have been made in the development of drugs to stimulate bone formation.

只看該作者 · 發(fā)表于 2025-3-24 22:21:56

Pharmacological Treatment of Bone Disorders,The pharmacological approach to disorders of bone remodeling is based mainly on drugs that inhibit osteoclastic bone resorption. Fewer advances have been made in the development of drugs to stimulate bone formation.

只看該作者 · 發(fā)表于 2025-3-25 01:07:11

		自動登錄	找回密碼
密碼			To register

關(guān)于派博傳思			派博傳思旗下網(wǎng)站			友情鏈接
派博傳思介紹	公司地理位置	論文服務(wù)流程	影響因子官網(wǎng)	吾愛論文網(wǎng)	大講堂	北京大學(xué)	Oxford Uni.	Harvard Uni.
發(fā)展歷史沿革	期刊點評	投稿經(jīng)驗總結(jié)	SCIENCEGARD	IMPACTFACTOR	派博系數(shù)	清華大學(xué)	Yale Uni.	Stanford Uni.
\|Archiver\|手機版\|小黑屋\| 派博傳思國際 ( 京公網(wǎng)安備110108008328) GMT+8, 2025-10-9 09:41
Copyright © 2001-2015 派博傳思京公網(wǎng)安備110108008328 版權(quán)所有 All rights reserved